FDA Inspection
Wuhan Humanwell Likang Pharmaceutical Co.,Ltd.Wuhan Humanwell Likang Pharmaceutical Co.,Ltd. – FDA Inspection, Aug 23, 2019
Record Details
This FDA Inspection record concerns Wuhan Humanwell Likang Pharmaceutical Co.,Ltd., with an inspection on August 23, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- August 23, 2019
- Product Type
- Human Drugs
- Person
- Kara D. Dobbin (Issuing Officer)
View Company Profile
ID · 1a7383f9-89ab-4d24-bdaf-dba775cc01de
Inspection Facts
- Inspection number
- 1113116
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Wuhan Humanwell Likang Pharmaceutical Co.,Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | Not classified | Office of Inspections and Investigations |
Other documents for Wuhan Humanwell Likang Pharmaceutical Co.,Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.